Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma

Sven H. Loosen, Fabian Benz, Jennifer Niedeggen, Maximilian Schmeding, Florian Schueller, Alexander Koch, Mihael Vucur, Frank Tacke, Christian Trautwein, Christoph Roderburg, Ulf P. Neumann, Tom Luedde*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Web of Science)
Original languageEnglish
Article number39
JournalClinical and Translational Medicine
Issue number1
Publication statusPublished - 27 Sep 2016


  • S100A6
  • Cholangiocarcinoma (CCA)
  • Cancer
  • Biomarker
  • Prognosis
  • CA19-9
  • CEA

Cite this